DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b730d3/iran_pharmaceutica) has announced the addition of the "Iran Pharmaceuticals and Healthcare Report Q1 2012" report to their offering.
Business Monitor International's Iran Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Iran's pharmaceuticals and healthcare industry.
BMI View:
Iran remains a very risky pharmaceutical market, not least due to its unsettled political situation. Theoretically speaking, however, it boasts a strong growth potential, propped up by the large population, which is forecast to reach nearly 79mn in 2016, and the reliance on imports for high-tech products. The government's fiscal spending will need to be reduced over the medium term, which will also weigh down on healthcare funding, given than it is responsible for about 45% of the total and some critics argue that co-payment levels are out of reach for some patients.
Key Trends And Developments:
In September, President Mahmoud Ahmadinejad emphasised the high potential of natural herbs for the treatment of different diseases, seeking a revival of traditional medicine during a meeting with World Health Organization (WHO) regional director Hassan Abdolrazzaq Jazzayeri. Ahmadinejad said the country may have to import more drugs and medicines unless traditional medicines are revived.
Arsalan Azhari, a minister from Kurdistan's department of planning affairs, said in September that Iran is ready to supply medical equipment to neighbouring states and that it has planned for an increase in medical tourism and sanitation services in Iraqi Kurdistan. Azhari said multiple memorandums of understanding (MoUs) have been signed between officials on both sides. I
The Iranian government plans to export medical radioisotopes to other countries in the region, the director of the Atomic Energy Organisation (IAEO), Abbasi Davani, said in September.
Key Topics Covered:
- SWOT Analysis
- Pharmaceutical Business Environment Ratings
- Industry Trends and Developments
- Industry Forecast Scenario
- Competitive Landscape
- Company Profiles
- Glossary
- Country Snapshot: Iran Demographic Data
For more information, including table of contents and list of companies mentioned, please visit http://www.researchandmarkets.com/research/b730d3/iran_pharmaceutica